tirzepatide news update Lilly's weight-loss drug removed from FDA's shortage list tirzepatide patent expiration us https://investor.lilly.com/news-releases/

Zhang N, Wang H, Ran S, et al

Patients with MASLD, MASH, or metabolic syndrome may benefit from LFT assessment at intervals consistent with American Association for the Study of Liver Diseases (AASLD) guidance

Southern Tick-Associated Rash Illness (STARI) A condition called STARI produces a rash that looks nearly identical to Lyme disease

Overall, rates of GLP-1 agonist use are highest among those between the ages of 50 and 64

Its a different tool for a different situation. Medical Supervision and Dose Adjustments At its core, microdosing is not a do-it-yourself concept

Financial support and sponsorship Nil Conflicts of interest There are no conflicts of interest